Understanding craniosynostosis as a growth disorder

Wiley Interdisciplinary Reviews: Developmental Biology

Volumn 5, Issue 4, 2016, Pages 429-459

  Flaherty, Kevin ^a   Singh, Nandini ^a   Richtsmeier, Joan T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST 1; UNCLASSIFIED DRUG;

ACROCEPHALOSYNDACTYLY; ANATOMY; COMPUTER ASSISTED TOMOGRAPHY; CRANIOFACIAL SYNOSTOSIS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GROWTH DISORDER; HUMAN; MESENCHYME CELL; MOLECULAR PATHOLOGY; MORPHOGENESIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 84975699494     PISSN: 17597684     EISSN: 17597692     Source Type: Journal    
DOI: 10.1002/wdev.227     Document Type: Review

References (234)

1. Lajeunie E, Merrer ML, Marchac D, Renier D . Syndromal and nonsyndromal primary trigonocephaly: analysis of a series of 237 patients. Am J Med Genet 1998, 75:211–215.
2. Slater BJ, Lenton KA, Kwan MD, Gupta DM, Wan DC, Longaker MT . Cranial sutures: a brief review. Plast Reconstr Surg 2008, 121:170e–178e. doi:10.1097/01.prs.0000304441.99483.97.
3. Hunter AG, Rudd NL . Craniosynostosis. I. Sagittal synostosis; its genetics and associated clinical findings in 214 patients who lacked involvement of the coronal suture (s). Teratology 1976, 14:185–193.
4. Singer S, Bower C, Southall P, Goldblatt J . Craniosynostosis in Western Australia, 1980–1994: a population-based study. Am J Med Genet 1999, 83:382–387.
5. Kardong KV . Vertebrates: Comparative Anatomy, Function, Evolution. New York: McGraw-Hill; 2012.
6. Opperman LA . Cranial sutures as intramembranous bone growth sites. Dev Dyn 2000, 219:472–485.
7. Beederman M, Farina EM, Reid RR . Molecular basis of cranial suture biology and disease: osteoblastic and osteoclastic perspectives. Genes Dis 2014, 1:120–125. doi:10.1016/j.gendis.2014.07.004.
8. Beenken A, Mohammadi M . The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009, 8:235–253. doi:10.1038/nrd2792.
9. Adams F . The Genuine Works of Hippocrates, vol. 17. London: Sydenham Society; 1849.
10. Vesalius A . De Humani Corporis Fabrica. San Francisco, CA: Norman Publishing; 1998.
11. Mehta VA, Bettegowda C, Jallo GI, Ahn ES . The evolution of surgical management for craniosynostosis. Neurosurg Focus 2010, 29:E5.
12. Cohen MM, MacLean RE . Craniosynostosis: Diagnosis, Evaluation, and Management. Baltimore, MD: JHU Press; 2000.
13. Gibson B . On the use of the sutures in the skulls of animals. Philos Mag Ser 1 1806, 24:256–262. doi:10.1080/14786440608563378.
14. Persing JA, Jane JA, Shaffrey M . Virchow and the pathogenesis of craniosynostosis: a translation of his original work. Plast Reconstr Surg 1989, 83:738–742.
15. Guimarães-Ferreira J, Miguéns J, Lauritzen CG . Advances in craniosynostosis research and management. Adv Tech Stand Neurosurg 2004, 29:23–83.
16. Delashaw JB, Persing JA, Broaddus WC, Jane JA . Cranial vault growth in craniosynostosis. J Neurosurg 1989, 70:159–165.
17. Delashaw JB, Persing JA, Jane JA . Cranial deformation in craniosynostosis. A new explanation. Neurosurg Clin N Am 1991, 2:611–620.
18. Moss ML . The pathogenesis of premature cranial synostosis in man. Cells Tissues Organs 1959, 37:351–370.
19. Moss ML, Young RW . A functional approach to craniology. Am J Phys Anthropol 1960, 18:281–292.
20. Moss-Salentijn L, Melvin L . Moss and the functional matrix. J Dent Res 1997, 76:1814–1817.
21. Cohen MM . Perspectives on craniosynostosis. West J Med 1980, 132:507.
22. Hukki J, Saarinen P, Kangasniemi M . Single suture craniosynostosis: diagnosis and imaging. Front Oral Biol 2008, 12:79–90.
23. Heuzé Y, Holmes G, Peter I, Richtsmeier JT, Jabs EW . Closing the gap: genetic and genomic continuum from syndromic to nonsyndromic craniosynostoses. Curr Genet Med Rep 2014, 2:135–145. doi:10.1007/s40142-014-0042-x.
24. Winter RM, Baraitser M . The London Dysmorphology Database. J Med Genet 1987, 24:509–510.
25. ®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD), 1/19/2015. World Wide Web URL: http://omim.org/.
26. Franz-Odendaal TA, Hall BK, Witten PE . Buried alive: how osteoblasts become osteocytes. Dev Dyn 2006, 235:176–190. doi:10.1002/dvdy.20603.
27. Lajeunie E, Ma HW, Bonaventure J, Munnich A, Le Merrer M, Renier D . FGFR2 mutations in Pfeiffer syndrome. Nat Genet 1995, 9:108.
28. Hunter AG, Rudd NL . Craniosynostosis. II. Coronal synostosis: its familial characteristics and associated clinical findings in 109 patients lacking bilateral polysyndactyly or syndactyly. Teratology 1977, 15:301–309.
29. Di Rocco F, Arnaud E, Renier D . Evolution in the frequency of nonsyndromic craniosynostosis: clinical article. J Neurosurg Pediatr 2009, 4:21–25.
30. Clayman MA, Murad GJ, Steele MH, Seagle MB, Pincus DW . History of craniosynostosis surgery and the evolution of minimally invasive endoscopic techniques: the University of Florida experience. Ann Plast Surg 2007, 58:285–287. doi:10.1097/01.sap.0000250846.12958.05.
31. Proctor M . Endoscopic craniosynostosis repair. Transl Pediatr 2014, 3:247–258.
32. Anantheswar YN, Venkataramana NK . Pediatric craniofacial surgery for craniosynostosis: our experience and current concepts: Part −1. J Pediatr Neurosci 2009, 4:86–99. doi:10.4103/1817-1745.57327.
33. McCarthy JG, Glasberg SB, Cutting CB, Epstein FJ, Grayson BH, Ruff G, Thorne CH, Wisoff J, Zide BM . Twenty-year experience with early surgery for craniosynostosis: II. The craniofacial synostosis syndromes and pansynostosis—results and unsolved problems. Plast Reconstr Surg 1995, 96:284–295; discussion 296–298.
34. Alvarez-Garijo JA, Cavadas PC, Vila MM, Alvarez-Llanas A . Sagittal synostosis: results of surgical treatment in 210 patients. Childs Nerv Syst 2001, 17:64–68.
35. Cohen MM, Kreiborg S . Growth pattern in the Apert syndrome. Am J Med Genet 1993, 47:617–623.
36. Scheuer L, Black SM . Developmental Juvenile Osteology. San Diego, CA: Academic Press; 2000.
37. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM . Tissue origins and interactions in the mammalian skull vault. Dev Biol 2002, 241:106–116. doi:10.1006/dbio.2001.0487.
38. Noden DM, Trainor PA . Relations and interactions between cranial mesoderm and neural crest populations. J Anat 2005, 207:575–601.
39. Gross JB, Hanken J . Review of fate-mapping studies of osteogenic cranial neural crest in vertebrates. Dev Biol 2008, 317:389–400. doi:10.1016/j.ydbio.2008.02.046.
40. Piekarski N, Gross JB, Hanken J . Evolutionary innovation and conservation in the embryonic derivation of the vertebrate skull. Nat Commun 2014, 5:5661. doi:10.1038/ncomms6661.
41. Hall BK, Miyake T . All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000, 22:138–147.
42. Morriss-Kay GM . Derivation of the mammalian skull vault. J Anat 2001, 199:143–151.
43. Percival CJ, Richtsmeier JT . Angiogenesis and intramembranous osteogenesis. Dev Dyn 2013, 242:909–922. doi:10.1002/dvdy.23992.
44. Long F . Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2011, 13:27–38. doi:10.1038/nrm3254.
45. Yang L, Tsang KY, Tang HC, Chan D, Cheah KSE . Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation. Proc Natl Acad Sci 2014, 111:12097–12102. doi:10.1073/pnas.1302703111.
46. Zhou X, von der Mark K, Henry S, Norton W, Adams H, de Crombrugghe B . Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet 2014, 10:e1004820. doi:10.1371/journal.pgen.1004820.
47. Carter DH, Sloan P, Aaron JE . Immunolocalization of collagen types I and III, tenascin, and fibronectin in intramembranous bone. J Histochem Cytochem 1991, 39:599–606.
48. Neve A, Corrado A, Cantatore FP . Osteoblast physiology in normal and pathological conditions. Cell Tissue Res 2011, 343:289–302. doi:10.1007/s00441-010-1086-1.
49. Ornitz DM, Marie PJ . FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002, 16:1446–1465.
50. Peck WA, Rifas L . Regulation of osteoblast activity and the osteoblast-osteocyte transformation. Adv Exp Med Biol 1982, 151:393–400.
51. Brugmann SA, Tapadia MD, Helms JA . The molecular origins of species-specific facial pattern. Curr Top Dev Biol 2006, 73:1–42.
52. Horton WA . The biology of bone growth. Growth Genet Horm 1990, 6:1–5.
53. Burr DB, Allen MR . Bone modeling and remodeling. In: Burr DB, Allen MR, eds. Basic and Applied Bone Biology. San Diego, CA: Academic Press; 2013, 75–90.
54. Bellido T, Plotkin LI, Bruzzaniti A . Bone cells. In: Burr DB, Allen MR, eds. Basic and Applied Bone Biology. San Diego, CA: Academic Press; 2013, 27–45.
55. Rucci N . Molecular biology of bone remodelling. Clin Cases Miner Bone Metab 2008, 5:49–56.
56. Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 2013, 19:179–192. doi:10.1038/nm.3074.
57. De Beer SG . The Development of the Vertebrate Skull. Chicago: The University of Chicago Press; 1937.
58. McBratney-Owen B, Iseki S, Bamforth SD, Olsen BR, Morriss-Kay GM . Development and tissue origins of the mammalian cranial base. Dev Biol 2008, 322:121–132. doi:10.1016/j.ydbio.2008.07.016.
59. Starck D . The development of the chondrocranium in primates. In: Luckett WP, Szalay FS, eds. Phylogeny of the Primates. New York: Plenum Press; 1975, 127–155.
60. Frisdal A, Trainor PA . Development and evolution of the pharyngeal apparatus. WIREs Dev Biol 2014, 3:403–418.
61. Chai Y, Maxson RE . Recent advances in craniofacial morphogenesis. Dev Dyn 2006, 235:2353–2375.
62. Marcucio RS, Young NM, Hu D, Hallgrimsson B . Mechanisms that underlie co-variation of the brain and face. Genesis 2011, 49:177–189. doi:10.1002/dvg.20710.
63. Richman JM, Lee S-H . About face: signals and genes controlling jaw patterning and identity in vertebrates. Bioessays 2003, 25:554–568.
64. Pritchard JJ, Scott JH, Girgis FG . The structure and development of cranial and facial sutures. J Anat 1956, 90:73.
65. Bradley J, Levine J, Roth D, McCarthy J, Longaker M . Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse. Plast Reconstr Surg 1996, 98:1039–1045.
66. Matsumura G, Uchiumi T, Kida K, Ichikawa R, Kodama G . Developmental studies on the interparietal part of the human occipital squama. J Anat 1993, 182(Pt 2):197–204.
67. Matsumura G, England MA, Uchiumi T, Kodama G . The fusion of ossification centres in the cartilaginous and membranous parts of the occipital squama in human fetuses. J Anat 1994, 185:295.
68. De Beer GR . Embryos and Ancestors. London: Oxford University Press; 1951.
69. Dixon AD, Hoyte DA, Rönning O . Fundamentals of Craniofacial Growth. New York: CRC Press; 1997.
70. Richtsmeier JT, Flaherty K . Hand in glove: brain and skull in development and dysmorphogenesis. Acta Neuropathol (Berl) 2013, 125:469–489. doi:10.1007/s00401-013-1104-y.
71. Zollikofer CPE, Ponce de León MS . The evolution of hominin ontogenies. Semin Cell Dev Biol 2010, 21:441–452. doi:10.1016/j.semcdb.2009.10.012.
72. Morriss-Kay GM, Wilkie AO . Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 2005, 207:637–653.
73. Wilkie AO . Craniosynostosis: genes and mechanisms. Hum Mol Genet 1997, 6:1647–1656.
74. Renier D, Sainte-Rose C, Marchac D, Hirsch JF . Intracranial pressure in craniostenosis. J Neurosurg 1982, 57:370–377. doi:10.3171/jns.1982.57.3.0370.
75. Renier D . Intracranial pressure in craniosynostosis: pre-and postoperative recordings—correlation with functional results. In: Persing JA, Edgerton MT, Jane JA, eds. Scientific Foundations and Surgical Treatment of Craniosynostosis. Baltimore, MD: Williams & Wilkins; 1989, 263.
76. Derderian C, Seaward J . Syndromic craniosynostosis. Semin Plast Surg 2012, 26:64–75. doi:10.1055/s-0032-1320064.
77. Opperman LA, Persing JA, Sheen R, Ogle RC . In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration. J Craniofac Surg 1994, 5:327–332.
78. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC . Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dyn 1993, 198:312–322.
79. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC . Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 1995, 10:1978–1987. doi:10.1002/jbmr.5650101218.
80. Opperman LA, Passarelli RW, Nolen AA, Gampper TJ, Lin KY, Ogle RC . Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol-Anim 1996, 32:627–632.
81. Lenton KA, Nacamuli RP, Wan DC, Helms JA, Longaker MT . Cranial suture biology. Curr Top Dev Biol 2005, 66:287–328.
82. Pritchard JJ . A cytological and histochemical study of bone and cartilage formation in the rat. J Anat 1952, 86:259.
83. Komori T, Kishimoto T . Cbfa1 in bone development. Curr Opin Genet Dev 1998, 8:494–499.
84. Johnson D, Wall SA, Mann S, Wilkie AO . A novel mutation, Ala315Ser, in FGFR2: a gene-environment interaction leading to craniosynostosis? Eur J Hum Genet 2000, 8:571.
85. Connerney J, Andreeva V, Leshem Y, Muentener C, Mercado MA, Spicer DB . Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 2006, 235:1334–1346. doi:10.1002/dvdy.20717.
86. Rice DPC, Connor EC, Veltmaat JM, Lana-Elola E, Veistinen L, Tanimoto Y, Bellusci S, Rice R . Gli3Xt-J/Xt-J mice exhibit lambdoid suture craniosynostosis which results from altered osteoprogenitor proliferation and differentiation. Hum Mol Genet 2010, 19:3457–3467. doi:10.1093/hmg/ddq258.
87. Holmes G, van Bakel H, Zhou X, Losic B, Jabs EW . BCL11B expression in intramembranous osteogenesis during murine craniofacial suture development. Gene Expr Patterns 2015, 17:16–25. doi:10.1016/j.gep.2014.12.001.
88. Zhao H, Feng J, Ho T-V, Grimes W, Urata M, Chai Y . The suture provides a niche for mesenchymal stem cells of craniofacial bones. Nat Cell Biol 2015, 17:386–396. doi:10.1038/ncb3139.
89. Martinez-Abadias N, Holmes G, Pankratz T, Wang Y, Zhou X, Jabs EW, Richtsmeier JT . From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome. Dis Model Mech 2013, 6:768–779. doi:10.1242/dmm.010397.
90. Boyadjiev SA . Genetic analysis of non-syndromic craniosynostosis. Orthod Craniofac Res 2007, 10:129–137.
91. Fragale A, Tartaglia M, Bernardini S, Di Stasi AM, Di Rocco C, Velardi F, Teti A, Battaglia PA, Migliaccio S . Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am J Pathol 1999, 154:1465–1477. doi:10.1016/S0002-9440(10)65401-6.
92. Lemonnier J, Delannoy P, Hott M, Lomri A, Modrowski D, Marie PJ . The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res 2000, 256:158–167. doi:10.1006/excr.2000.4820.
93. Jabs EW, Müller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB . A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 1993, 75:443–450.
94. Kim H-J, Rice DP, Kettunen PJ, Thesleff I . FGF-, BMP-and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998, 125:1241–1251.
95. Crouzon O . Dysostose cranio-faciale hereditaire. Presse Med 1912, 20:737–739.
96. Mohr OL . Dominant acrocephalosyndactyly. Hereditas 1939, 25:193–203.
97. Passos-Bueno M, Sertie A, Jehee F, Fanganiello R, Yeh E . Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. In: Rice DP, ed. Craniofacial Sutures. Development, Disease and Treatment. London/Helsinki: Karger Medical and Scientific Publishers; 2008, 107–143.
98. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P . Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995, 9:165–172.
99. Fanganiello RD, Sertié AL, Reis EM, Yeh E, Oliveira NA, Bueno DF, Kerkis I, Alonso N, Cavalheiro S, Matsushita H . Apert p. Ser252Trp mutation in FGFR2 alters osteogenic potential and gene expression of cranial periosteal cells. Mol Med 2007, 13:422.
100. Chen P, Zhang L, Weng T, Zhang S, Sun S, Chang M, Li Y, Zhang B, Zhang L . A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation. PLoS One 2014, 9:e87311.
101. Oldridge M, Lunt PW, Zackai EH, McDonald-McGinn DM, Muenke M, Moloney DM, Twigg SR, Heath JK, Howard TD, Hoganson G . Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum Mol Genet 1997, 6:137–143.
102. Yin L, Du X, Li C, Xu X, Chen Z, Su N, Zhao L, Qi H, Li F, Xue J, et al. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. Bone 2008, 42:631–643. doi:10.1016/j.bone.2007.11.019.
103. Galvin BD, Hart KC, Meyer AN, Webster MK, Donoghue DJ . Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR) 2 and FGFR2/Neu chimeras. Proc Natl Acad Sci 1996, 93:7894–7899.
104. Meyers GA, Day D, Goldberg R, Daentl DL, Przylepa KA, Abrams LJ, Graham JM Jr, Feingold M, Moeschler JB, Rawnsley E . FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet 1996, 58:491.
105. Gorry MC, Preston RA, White GJ, Zhang Y, Singhal VK, Losken HW, Parker MG, Nwokoro NA, Post JC, Ehrlich GD . Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson—Weiss syndrome. Hum Mol Genet 1995, 4:1387–1390.
106. Kan S, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S . Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 2002, 70:472–486.
107. Anderson J, Burns HD, Enriquez-Harris P, Wilkie AO, Heath JK . Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet 1998, 7:1475–1483.
108. Chun K, Teebi AS, Azimi C, Steele L, Ray PN . Screening of patients with craniosynostosis: molecular strategy. Am J Med Genet A 2003, 120:470–473.
109. Nur BG, Pehlivanoğlu S, Mıhçı E, Çalışkan M, Demir D, Alper ÖM, Kayserili H, Lüleci G . Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review. Pediatr Neurol 2014, 50:482–490.
110. Kress W, Collmann H, Büsse M, Halliger-Keller B, Mueller CR . Clustering of FGFR2 gene mutations in patients with Pfeiffer and Crouzon syndromes (FGFR2-associated craniosynostoses). Cytogenet Genome Res 2000, 91:134–137.
111. Mulliken JB, Steinberger D, Kunze S, Müller U . Molecular diagnosis of bilateral coronal synostosis. Plast Reconstr Surg 1999, 104:1603–1615.
112. Paumard-Hernández B, Berges-Soria J, Barroso E, Rivera-Pedroza CI, Pérez-Carrizosa V, Benito-Sanz S, López-Messa E, Santos F, García-Recuero II, Romance A, et al. Expanding the mutation spectrum in 182 Spanish probands with craniosynostosis: identification and characterization of novel TCF12 variants. Eur J Hum Genet 2015, 23:907–914. doi:10.1038/ejhg.2014.205.
113. Kress W, Collmann H, Büsse M, Halliger-Keller B, Mueller CR . Clustering of FGFR2 gene mutations in patients with Pfeiffer and Crouzon syndromes (FGFR2-associated craniosynostoses). Cytogenet Cell Genet 1999, 91:134–137.
114. Steinberger D, Müller U, Jünger TH, Howaldt HP, Christophis P . Mutation of FGFR2 (cys278phe) in craniolacunia and pansynostosis. J Med Genet 1999, 36:499–500.
115. Lajeunie E, Heuertz S, El Ghouzzi V, Martinovic J, Renier D, Le Merrer M, Bonaventure J . Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome. Eur J Hum Genet 2006, 14:289–298.
116. Oldridge M, Wilkie AOM, Sianey SF, Poole MD, Pulleyn LJ, Rutland P, Hockley AD, Wake MJC, Goldin JH, Winter RM, et al. Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet 1995, 4:1077–1082.
117. Park W-J, Meyers GA, Li X, Theda C, Day D, Oriow SJ, Jones MC, Jabs EW . Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 1995, 4:1229–1233.
118. Steinberger D, Collmann H, Schmalenberger B, Müller U . A novel mutation (a886g) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly. J Med Genet 1997, 34:420–422.
119. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao J, Charnas LR, Jackson CE, Jaye M . Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994, 8:275–279.
120. Pulleyn LJ, Reardon W, Wilkes D, Rutland P, Jones BM, Hayward R, Hall CM, Brueton L, Chun N, Lammer E . Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus. Eur J Hum Genet 1995, 4:283–291.
121. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S . Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994, 8:98–103.
122. Hollway GE, Suthers GK, Haan EA, Thompson E, David DJ, Gecz J, Mulley JC . Mutation detection in FGFR2 craniosynostosis syndromes. Hum Genet 1997, 99:251–255.
123. Ma HW, Lajeunie E, Le Merrer M, de Parseval N, Serville F, Weissenbach J, Munnich A, Renier D . No evidence of genetic heterogeneity in Crouzon craniofacial dysostosis. Hum Genet 1995, 96:731–735.
124. Tartaglia M, Di Rocco C, Lajeunie E, Valeri S, Velardi F, Battaglia PA . Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders. Hum Genet 1997, 101:47–50.
125. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF . Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 1995, 9:173–176.
126. Schell U, Hehr A, Feldman GJ, Robin NH, Zackai EH, de Die-Smulders C, Viskochil DH, Stewart JM, Wolff G, Ohashi H, et al. Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet 1995, 4:323–328.
127. Passos-Bueno MR, Sertie AL, Richieri-Costa A, Alonso LG, Zatz M, Alonso N, Brunoni D, Ribeiro SF . Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses. Am J Med Genet 1998, 78:237–241.
128. Fujisawa H, Hasegawa M, Kida S, Yamashita J . A novel fibroblast growth factor receptor 2 mutation in Crouzon syndrome associated with Chiari type I malformation and syringomyelia. J Neurosurg 2002, 97:396–400.
129. McCann E, Kaye SB, Newman W, Norbury G, Black G, Ellis IH . Novel phenotype of craniosynostosis and ocular anterior chamber dysgenesis with a fibroblast growth factor receptor 2 mutation. Am J Med Genet A 2005, 138:278–281.
130. Sharma VP, Wall SA, Lord H, Lester T, Wilkie AO . Atypical Crouzon syndrome with a novel Cys62Arg mutation in FGFR2 presenting with sagittal synostosis. Cleft Palate Craniofac J 2012, 49:373–377.
131. Lin Y, Ai S, Chen C, Liu X, Luo L, Ye S, Liang X, Zhu Y, Yang H, Liu Y . Ala344Pro mutation in the FGFR2 gene and related clinical findings in one Chinese family with Crouzon syndrome. Mol Vis 2012, 18:1278.
132. Stevens CA, Roeder ER . Ser351Cys mutation in the fibroblast growth factor receptor 2 gene results in severe Pfeiffer syndrome. Clin Dysmorphol 2006, 15:187–188.
133. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW . Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995, 11:462–464.
134. Wilkes D, Rutland P, Pulleyn LJ, Reardon W, Moss C, Ellis JP, Winter RM, Malcolm S . A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J Med Genet 1996, 33:744–748.
135. Vajo Z, Francomano CA, Wilkin DJ . The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans 1. Endocr Rev 2000, 21:23–39.
136. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S . A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994, 8:269–274.
137. Tartaglia M, Valeri S, Velardi F, Di Rocco C, Battaglia PA . Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome. Hum Genet 1997, 99:602–606.
138. Tsukuno M, Suzuki H, Eto Y . Pfeiffer syndrome caused by haploinsufficient mutation of FGFR2. J Craniofac Genet Dev Biol 1998, 19:183–188.
139. Gripp KW, Stolle CA, McDonald-McGinn DM, Markowitz RI, Bartlett SP, Katowitz JA, Muenke M, Zackai EH . Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III. Am J Med Genet 1998, 78:356–360.
140. Júnior H-M, de Aquino S-N, Machado R-A, Leão L-L, Coletta R-D, Burle-Aguiar M-J . Pfeiffer syndrome: clinical and genetic findings in five Brazilian families. Med Oral Patol Oral Cir Bucal 2015, 20:e52.
141. Wilkie AOM, Byren JC, Hurst JA, Jayamohan J, Johnson D, Knight SJL, Lester T, Richards PG, Twigg SRF, Wall SA . Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics 2010, 126:e391–e400. doi:10.1542/peds.2009-3491.
142. Oldridge M, Zackai EH, McDonald-McGinn DM, Iseki S, Morriss-Kay GM, Twigg SR, Johnson D, Wall SA, Jiang W, Theda C . De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet 1999, 64:446–461.
143. Chokdeemboon C, Mahatumarat C, Rojvachiranonda N, Tongkobpetch S, Suphapeetiporn K, Shotelersuk V . FGFR1 and FGFR2 mutations in Pfeiffer syndrome. J Craniofac Surg 2013, 24:150–152. doi:10.1097/SCS.0b013e3182646454.
144. Johnson D, Horsley SW, Moloney DM, Oldridge M, Twigg SR, Walsh S, Barrow M, Njølstad PR, Kunz J, Ashworth GJ . A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am J Hum Genet 1998, 63:1282–1293.
145. Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD, Jabs EW . Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 1997, 15:36–41. doi:10.1038/ng0197-36.
146. Paznekas WA, Cunningham ML, Howard TD, Korf BR, Lipson MH, Grix AW, Feingold M, Goldberg R, Borochowitz Z, Aleck K . Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet 1998, 62:1370–1380.
147. El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin A-L, Munnich A, Bonaventure J . Mutations of the TWIST gene in the Saethre-Chotzene syndrome. Nat Genet 1997, 15:42–46.
148. Rose CSP, Patel P, Reardon W, Malcolm S, Winter RM . The TWIST gene, although not disrupted in Saethre-Chotzen patients with apparently balanced translocations of 7p21, is mutated in familial and sporadic cases. Hum Mol Genet 1997, 6:1369–1373.
149. Woods RH, Ul-Haq E, Wilkie AO, Jayamohan J, Richards PG, Johnson D, Lester T, Wall SA . Reoperation for intracranial hypertension in TWIST1 confirmed Saethre-Chotzen syndrome: a 15 year review. Plast Reconstr Surg 2009, 123:1801.
150. Elanko N, Sibbring JS, Metcalfe KA, Clayton-Smith J, Donnai D, Temple IK, Wall SA, Wilkie AO . A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals. Hum Mutat 2001, 18:535–541.
151. Wilkie AO, Bochukova EG, Hansen R, Taylor IB, Rannan-Eliya SV, Byren JC, Wall SA, Ramos L, Venâncio M, Hurst JA . Clinical dividends from the molecular genetic diagnosis of craniosynostosis. Am J Med Genet A 2006, 140:2631–2639.
152. Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997, 60:555.
153. Warman ML, Mulliken JB, Hayward PG, Müller U . Newly recognized autosomal dominant disorder with craniosynostosis. Am J Med Genet 1993, 46:444–449.
154. Sharma VP, Fenwick AL, Brockop MS, McGowan SJ, Goos JAC, Hoogeboom AJM, Brady AF, Jeelani NO, Lynch SA, Mulliken JB, et al. Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet 2013, 45:304–307. doi:10.1038/ng.2531.
155. Justice CM, Yagnik G, Kim Y, Peter I, Jabs EW, Erazo M, Ye X, Ainehsazan E, Shi L, Cunningham ML, et al. A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet 2012, 44:1360–1364. doi:10.1038/ng.2463.
156. Twigg SR, Forecki J, Goos JA, Richardson IC, Hoogeboom AJM, van den Ouweland AM, Swagemakers SM, Lequin MH, Van Antwerp D, McGowan SJ . Gain-of-function mutations in ZIC1 are associated with coronal craniosynostosis and learning disability. Am J Hum Genet 2015, 97:378–388.
157. Twigg SRF, Wilkie AOM . A genetic-pathophysiological framework for craniosynostosis. Am J Hum Genet 2015, 97:359–377. doi:10.1016/j.ajhg.2015.07.006.
158. Hajihosseini M . Fibroblast growth factor signaling in cranial suture development and pathogenesis. In: Rice DP, ed. Craniofacial Sutures. Development, Disease and Treatment. London/Helsinki: Karger Medical and Scientific Publishers; 2008.
159. Marie PJ, Coffin JD, Hurley MM . FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J Cell Biochem 2005, 96:888–896. doi:10.1002/jcb.20582.
160. Marie P, Kaabeche K, Guenou H . Roles of FGFR2 and twist in human craniosynostosis: insights from genetic mutations in cranial osteoblasts. In: Rice DP, ed. Craniofacial Sutures. Development, Disease and Treatment. London/Helsinki: Karger Medical and Scientific Publishers; 2008.
161. Merrill AE . Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet 2006, 15:1319–1328. doi:10.1093/hmg/ddl052.
162. Ting M-C, Wu NL, Roybal PG, Sun J, Liu L, Yen Y, Maxson RE . EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis. Development 2009, 136:855–864. doi:10.1242/dev.028605.
163. Connerney J, Andreeva V, Leshem Y, Mercado MA, Dowell K, Yang X, Lindner V, Friesel RE, Spicer DB . Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 2008, 318:323–334. doi:10.1016/j.ydbio.2008.03.037.
164. Maxson R, Ishii M . The Bmp pathway in skull vault development. In: Rice DP, ed. Craniofacial Sutures. Development, Disease and Treatment. London/Helsinki: Karger Medical and Scientific Publishers; 2008.
165. Marie PJ . Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003, 316:23–32. doi:10.1016/S0378-1119(03)00748-0.
166. Jehee FS, Bertola DR, Yelavarthi KK, Krepischi-Santos ACV, Kim C, Vianna-Morgante AM, Vermeesch JR, Passos-Bueno MR . An 11q11–q13.3 duplication, includingFGF3 andFGF4 genes, in a patient with syndromic multiple craniosynostoses. Am J Med Genet A 2007, 143A:1912–1918. doi:10.1002/ajmg.a.31863.
167. Mefford HC, Shafer N, Antonacci F, Tsai JM, Park SS, Hing AV, Rieder MJ, Smyth MD, Speltz ML, Eichler EE . Copy number variation analysis in single-suture craniosynostosis: multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis. Am J Med Genet A 2010, 152:2203–2210.
168. FitzPatrick DR . Filling in the gaps in cranial suture biology. Nat Genet 2013, 45:231–232.
169. Thomson AW, Lotze MT . The Cytokine Handbook, Two-Volume Set. London/San Diego: Gulf Professional Publishing; 2003.
170. Schuller A, Ahmed Z, Ladbury J . Extracellular point mutations in FGFR2 result in elevated ERK1/2 activation and perturbation of neuronal differentiation. Biochem J 2008, 410:205–211.
171. Mohammadi M, Olsen SK, Ibrahimi OA . Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev 2005, 16:107–137. doi:10.1016/j.cytogfr.2005.01.008.
172. Zhang X . Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family. J Biol Chem 2006, 281:15694–15700. doi:10.1074/jbc.M601252200.
173. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ . Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994, 78:335–342.
174. Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M . Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci 2001, 98:7182–7187.
175. Mai S, Wei K, Flenniken A, Adamson SL, Rossant J, Aubin JE, Gong S-GG . The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling. Dev Dyn 2010, 239:1888–1900. doi:10.1002/dvdy.22314.
176. Maeno T, Moriishi T, Yoshida CA, Komori H, Kanatani N, Izumi S, Takaoka K, Komori T . Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. Bone 2011, 49:673–682. doi:10.1016/j.bone.2011.07.023.
177. Komori T . Signaling networks in RUNX2-dependent bone development. J Cell Biochem 2011, 112:750–755.
178. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004, 6:423–435.
179. Miraoui H, Marie PJ . Pivotal role of Twist in skeletal biology and pathology. Gene 2010, 468:1–7. doi:10.1016/j.gene.2010.07.013.
180. Iseki S, Wilkie AO, Morriss-Kay GM . Fgfr1 and Fgfr2 have distinct differentiation-and proliferation-related roles in the developing mouse skull vault. Development 1999, 126:5611–5620.
181. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesleff I . Integration of FGF and TWIST in calvarial bone and suture development. Development 2000, 127:1845–1855.
182. Rice DP, Rice R, Thesleff I . Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis. Eur J Orthod 2003, 25:139–148.
183. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE . Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev Biol 1999, 205:260–274. doi:10.1006/dbio.1998.9114.
184. Iseki S, Wilkie AO, Heath JK, Ishimaru T, Eto K, Morriss-Kay GM . Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 1997, 124:3375–3384.
185. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T . BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 2008, 283:29119–29125. doi:10.1074/jbc.M801774200.
186. Bush JO, Soriano P . Eph/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches. Semin Cell Dev Biol 2012, 23:26–34. doi:10.1016/j.semcdb.2011.10.018.
187. Kullander K, Klein R . Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 2002, 3:475–486.
188. Bush JO, Soriano P . Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries. Genes Dev 2010, 24:2068–2080. doi:10.1101/gad.1963210.
189. Twigg SR, Kan R, Babbs C, Bochukova EG, Robertson SP, Wall SA, Morriss-Kay GM, Wilkie AO . Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci USA 2004, 101:8652–8657.
190. Wieland I, Jakubiczka S, Muschke P, Cohen M, Thiele H, Gerlach KL, Adams RH, Wieacker P . Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am J Hum Genet 2004, 74:1209–1215.
191. Heuzé Y, Martínez-Abadías N, Stella JM, Senders CW, Boyadjiev SA, Lo L-J, Richtsmeier JT . Unilateral and bilateral expression of a quantitative trait: asymmetry and symmetry in coronal craniosynostosis. J Exp Zool B Mol Dev Evol 2012, 318:109–122.
192. Twigg SRF, Vorgia E, McGowan SJ, Peraki I, Fenwick AL, Sharma VP, Allegra M, Zaragkoulias A, Sadighi Akha E, Knight SJL, et al. Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet 2013, 45:308–313. doi:10.1038/ng.2539.
193. Heuzé Y, Martínez-Abadías N, Stella JM, Arnaud E, Collet C, García Fructuoso G, Alamar M, Lo L-JJ, Boyadjiev SA, Di Rocco F, et al. Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes. Birth Defects Res Clin Mol Teratol 2014, 100:250–259. doi:10.1002/bdra.23228.
194. Roux J, Robinson-Rechavi M . Developmental constraints on vertebrate genome evolution. PLoS Genet 2008, 4:e1000311.
195. Grova M, Lo DD, Montoro D, Hyun JS, Chung MT, Wan DC, Longaker MT . Models of cranial suture biology. J Craniofac Surg 2012, 23:S12–S16. doi:10.1097/SCS.0b013e318258ba53.
196. Holmes G . Mouse models of Apert syndrome. Childs Nerv Syst 2012, 28:1505–1510. doi:10.1007/s00381-012-1872-z.
197. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P . Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci 1998, 95:5082–5087.
198. Yamaguchi TP, Harpal K, Henkemeyer M, Rossant J . fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 1994, 8:3032–3044.
199. Friedel RH, Wurst W, Wefers B, Kühn R . Generating conditional knockout mice. In: Transgenic Mouse: Methods and Protocols. Totowa, NJ: Springer; 2011, 205–231.
200. Wilkie AOM . Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 2005, 16:187–203. doi:10.1016/j.cytogfr.2005.03.001.
201. Zhou Y-X, Xu X, Chen L, Li C, Brodie SG, Deng C-X . A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 2000, 9:2001–2008.
202. Roscioli T, Flanagan S, Kumar P, Masel J, Gattas M, Hyland VJ, Glass IA . Clinical findings in a patient with FGFR1 P252R mutation and comparison with the literature. Am J Med Genet 2000, 93:22–28.
203. Purushothaman R, Cox TC, Muga AM, Cunningham ML . Facial suture synostosis of newborn Fgfr1P250R/+ and Fgfr2S252W/+ mouse models of Pfeiffer and Apert syndromes. Birth Defects Res A Clin Mol Teratol 2011, 91:603–609. doi:10.1002/bdra.20811.
204. Chen L, Li D, Li C, Engel A, Deng C-X . A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 2003, 33:169–178. doi:10.1016/S8756-3282(03)00222-9.
205. +/S252W mouse. Development 2005, 132:3537–3548. doi:10.1242/dev.01914.
206. +P253R mice. BMC Dev Biol 2010, 10:22.
207. Cunningham ML, Seto ML, Ratisoontorn C, Heike CL, Hing AV . Syndromic craniosynostosis: from history to hydrogen bonds. Orthod Craniofac Res 2007, 10:67–81. doi:10.1111/j.1601-6343.2007.00389.x.
208. Nagata M, Nuckolls GH, Wang X, Shum L, Seki Y, Kawase T, Takahashi K, Nonaka K, Takahashi I, Noman AA, et al. The primary site of the acrocephalic feature in Apert syndrome is a dwarf cranial base with accelerated chondrocytic differentiation due to aberrant activation of the FGFR2 signaling. Bone 2011, 48:847–856. doi:10.1016/j.bone.2010.11.014.
209. Aldridge K, Hill CA, Austin JR, Percival C, Martinez-Abadias N, Neuberger T, Wang Y, Jabs EW, Richtsmeier JT . Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev Dyn 2010, 239:987–997. doi:10.1002/dvdy.22218.
210. Martínez-Abadías N, Percival C, Aldridge K, Hill CA, Ryan T, Sirivunnabood S, Wang Y, Jabs EW, Richtsmeier JT . Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth. Dev Dyn 2010, 239:3058–3071. doi:10.1002/dvdy.22414.
211. Kreiborg S, Marsh JL, Cohen MM, Liversage M, Pedersen H, Skovby F, Børgesen SE, Vannier MW . Comparative three-dimensional analysis of CT-scans of the calvaria and cranial base in Apert and Crouzon syndromes. J Cranio-Maxillofac Surg 1993, 21:181–188.
212. Motch-Perrine SMM, Cole TM, Martínez-Abadías N, Aldridge K, Jabs EW, Richtsmeier JT . Craniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant mice. BMC Dev Biol 2014, 14:8.
213. Holmes G, Rothschild G, Roy UB, Deng C-X, Mansukhani A, Basilico C . Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev Biol 2009, 328:273–284. doi:10.1016/j.ydbio.2009.01.026.
214. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P . A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 2004, 101:12555–12560.
215. Martínez-Abadías N, Motch SM, Pankratz TL, Wang Y, Aldridge K, Jabs EW, Richtsmeier JT . Tissue-specific responses to aberrant FGF signaling in complex head phenotypes. Dev Dyn 2013, 242:80–94. doi:10.1002/dvdy.23903.
216. Schaefer F, Anderson C, Can B, Say B . Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case. Am J Med Genet 1998, 75:252–255.
217. Cohen MM . Sutural biology and the correlates of craniosynostosis. Am J Med Genet 1993, 47:581–616.
218. Gong S-GG . The Fgfr2 W290R mouse model of Crouzon syndrome. Childs Nerv Syst 2012, 28:1495–1503. doi:10.1007/s00381-012-1792-y.
219. Twigg SRF, Healy C, Babbs C, Sharpe JA, Wood WG, Sharpe PT, Morriss-Kay GM, Wilkie AOM . Skeletal analysis of the Fgfr3P244R mouse, a genetic model for the Muenke craniosynostosis syndrome. Dev Dyn 2009, 238:331–342. doi:10.1002/dvdy.21790.
220. Nah H-DD, Koyama E, Agochukwu NB, Bartlett SP, Muenke M . Phenotype profile of a genetic mouse model for Muenke syndrome. Childs Nerv Syst 2012, 28:1483–1493. doi:10.1007/s00381-012-1778-9.
221. Brookes CD, Golden BA, Turvey TA . Craniosynostosis syndromes. Atlas Oral Maxillofac Surg Clin North Am 2014, 22:103–110.
222. Motch-Perrine S, Rhodes K, Wu M, Sun M, Jabs EW, Richtsmeier JT . Late prenatal effects of the Fgfr3 P244R mutation on murine craniofacial phenotype. Presented at the 38th Annual Meeting of the Society of Craniofacial Genetics, Baltimore, MD, 2015.
223. Saethre H . Ein Beitrag zum Turmschädelproblem,(Pathogenese, Erblichkeit und Symptomatologie). Dtsch Z Nervenheilkd 1931, 117:533–555.
224. Chotzen F . Eine eigenartige familiaere Entwicklungsstoerung (Akrocephalosyndaktylie, Dysostosis craniofacialis und Hypertelorismus). Mschr Kinderheilk 1931, 55:97–122.
225. Irvine KD, Rauskolb C . Boundaries in development: formation and function. Annu Rev Cell Dev Biol 2001, 17:189–214.
226. Meinhardt H . Cell determination boundaries as organizing regions for secondary embryonic fields. Dev Biol 1983, 96:375–385.
227. Deckelbaum RA, Holmes G, Zhao Z, Tong C, Basilico C, Loomis CA . Regulation of cranial morphogenesis and cell fate at the neural crest-mesoderm boundary by engrailed 1. Development 2012, 139:1346–1358. doi:10.1242/dev.076729.
228. Behr B, Longaker MT, Quarto N . Craniosynostosis of coronal suture in Twist1+/− mice occurs through endochondral ossification recapitulating the physiological closure of posterior frontal suture. Front Physiol 2011, 2:37.
229. Parsons TE, Weinberg SM, Khaksarfard K, Howie RN, Elsalanty M, Yu JC, Cray JJ . Craniofacial shape variation in Twist1+/− mutant mice. Anat Rec 2014, 297:826–833.
230. Doherty ES, Lacbawan F, Hadley DW, Brewer C, Zalewski C, Kim HJ, Solomon B, Rosenbaum K, Domingo DL, Hart TC, et al. Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet A 2007, 143A:3204–3215. doi:10.1002/ajmg.a.32078.
231. Lee HQ, Hutson JM, Wray AC, Lo PA, Chong DK, Holmes AD, Greensmith AL . Changing epidemiology of nonsyndromic craniosynostosis and revisiting the risk factors. J Craniofac Surg 2012, 23:1245–1251.
232. Boulet SL, Rasmussen SA, Honein MA . A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A 2008, 146A:984–991. doi:10.1002/ajmg.a.32208.
233. Shukla V, Coumoul X, Wang R-H, Kim H-S, Deng C-X . RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat Genet 2007, 39:1145–1150.
234. Buchanan AV, Sholtis S, Richtsmeier J, Weiss KM . What are genes “for” or where are traits “from”? What is the question? Bioessays 2009, 31:198–208. doi:10.1002/bies.200800133.